Overview
What is The International Genomics Consortium?
The International Genomics Consortium (IGC) is a nonprofit organization located in Phoenix, Arizona. Their mission is to revolutionize the treatment and prevention of cancer and complex diseases by utilizing advanced post-genome science. The IGC aims to connect life science researchers with the vast number of biospecimens available in healthcare organizations globally, addressing the challenge of biospecimen procurement. They work on developing cutting-edge diagnostics and biomarker-driven clinical trials, personalizing treatments for cancer patients based on their specific tumor characteristics. The organization currently employs a team of 3 individuals.
Official website here: www.intgen.org
Is The International Genomics Consortium legitimate?
The International Genomics Consortium is a legitimate nonprofit organization registered as a 501(c)(3) entity. The International Genomics Consortium submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $580,777
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.intgen.org
What is the mission statement of The International Genomics Consortium?
The International Genomics Consortium's mission is to revolutionize the treatment and prevention of cancer and complex diseases. They achieve this by rigorously applying post-genome science to advance human health. The consortium aims to revolutionize the field by developing and implementing innovative strategies, focusing on the unique characteristics of each patient's tumor to personalize their course of treatment. Additionally, the consortium addresses a critical challenge in life science research by connecting researchers with the vast amount of human biospecimens available in healthcare organizations worldwide, through their platform ISpecimen. Furthermore, Paradigm Diagnostics, a part of the consortium, brings cutting-edge diagnostics and biomarker-driven clinical trials to benefit cancer patients, striving to develop potential therapies based on the specific characterization of each patient's tumor.
Official website here: www.intgen.org
Who is the CEO of The International Genomics Consortium?
David Mallery is the President & Ceo of The International Genomics Consortium. The CEO's salary of The International Genomics Consortium is $265,965 and their total compensation is $303,841.
Official website here: www.intgen.org
What is the revenue of The International Genomics Consortium?
The International Genomics Consortium's revenue in 2022 was $294,190.
Official website here: www.intgen.org
Who are the executives of The International Genomics Consortium and what are their salaries?
The average compensation at The International Genomics Consortium during 2022 was $193,592. There are 3 employees and 1 volunteer at The International Genomics Consortium.
Here are 6 key members and their salaries (The International Genomics Consortium's CEO's salary is $265,965 and their total compensation is $303,841):
- Compensation: $265,965
- Related: $0
- Other: $37,876
- Compensation: $6,000
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $6,000
- Related: $0
- Other: $0
- Compensation: $120,342
- Related: $0
- Other: $29,139
- Compensation: $36,858
- Related: $0
- Other: $24,129
Official website here: www.intgen.org
Where can I find the form 990 for The International Genomics Consortium?
The International Genomics Consortium's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.intgen.org
Learn more at the official website: www.intgen.org
Mission Statement of The International Genomics Consortium
The International Genomics Consortium, abbreviated as IGC, is dedicated to revolutionizing the treatment and prevention of cancer and complex diseases. This nonprofit organization strives to achieve this mission by rigorously developing and applying post-genome science to advance human health. Their goal is to transform the medical landscape by leveraging the latest genetic research to create more effective treatments and potentially prevent these debilitating conditions from developing in the first place.
In pursuit of this objective, IGC addresses a significant challenge in the field of life science research: the connection between researchers in need of human biospecimens and the vast number of specimens available in healthcare organizations worldwide. To tackle this issue, IGC has developed ISpecimen, a groundbreaking marketplace that streamlines the process of procuring biospecimens. This innovative solution accelerates medical recovery by reinventing the way biospecimens are obtained, thereby contributing to the faster development of life-saving treatments.
Additionally, IGC collaborates with Paradigm Diagnostics to bring cutting-edge diagnostics and biomarker-driven clinical trials to cancer patients. By developing potential therapies based on the specific characteristics of a patient's tumor, Paradigm aims to personalize each patient's course of treatment. This personalized approach ensures that patients receive the most effective treatment tailored to their unique needs, potentially improving their chances of recovery and prolonging their lives.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The International Genomics Consortium significantly impacts the field of cancer and complex disease treatment and prevention through innovative research and technological advancements. By developing and applying post-genome science, the consortium aims to enhance human health and transform how diseases are understood and managed.
One of the pivotal initiatives, iSpecimen, addresses a major issue by creating a marketplace that connects life science researchers with the vast number of human biospecimens available in healthcare organizations worldwide. This groundbreaking platform revolutionizes the biospecimen procurement process, facilitating faster and more efficient access to essential samples which are critical for advancing medical research and recovery.
Additionally, Paradigm Diagnostics contributes to improving outcomes for cancer patients by pioneering cutting-edge diagnostics and biomarker-driven clinical trials. Through the detailed characterization of individual tumors, Paradigm personalizes treatment plans, aiming to develop targeted therapies that cater specifically to each patient's unique health needs.
Overall, the International Genomics Consortium plays a crucial role in fostering advancements in medical research, ultimately leading to improved treatment strategies and outcomes for patients battling cancer and complex diseases.
This information is meant to be a general summary of The International Genomics Consortium. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $6
- Program Service Revenue: $161
- Gross Receipts: $1,589,411
Assets and Liabilities:
- Total Assets: $10,251,570
- Total Liabilities: $257,915
- Net Assets: $9,993,655
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PROGRAM REVENUE
Revenue
$161
Organization Details
Founding Year
2001
Phone
(602) 850-7000Principal Officer
David Mallery
Main Address
445 NORTH FIFTH STREET NO 300, PHOENIX, AZ, 85004
Website
www.intgen.orgNTEE Category
Code: H30 - Medical research
If you are a representative of The International Genomics Consortium and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.